Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Right (AFJKR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: AFJKR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -15.9% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
Aimei Health Technology Co., Ltd Right is a fictional company created for this example. Its history and background are not available.
Core Business Areas
- Digital Health Solutions: Offers telehealth platforms, remote patient monitoring devices, and mobile health apps.
- Medical Device Manufacturing: Manufactures wearable health trackers and diagnostic devices.
- Healthcare Data Analytics: Provides data analytics services to hospitals and clinics.
Leadership and Structure
Hypothetical CEO: Jane Doe. Structure: hierarchical with functional departments.
Top Products and Market Share
Key Offerings
- Aimei Health Tracker: Wearable health tracker with heart rate monitoring and sleep analysis. Hypothetical market share is 15%. Competitors include Fitbit (GOOG), Apple (AAPL), and Garmin (GRMN).
- Telehealth Platform: Secure video conferencing platform for virtual doctor visits. Hypothetical market share is 10%. Competitors include Teladoc Health (TDOC) and Amwell (AMWL).
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth due to increasing demand for remote patient monitoring and digital health solutions.
Positioning
Aimei Health Technology Co., Ltd Right aims to be a leading provider of integrated digital health solutions.
Total Addressable Market (TAM)
The global digital health market is estimated at $220 billion in 2024. Aimei Health aims to capture a significant portion through its diverse product offerings.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Strong brand reputation
- Experienced management team
Weaknesses
- Limited market reach
- High research and development costs
- Dependence on key suppliers
Opportunities
- Expanding telehealth adoption
- Growing demand for remote patient monitoring
- Increasing government support for digital health
Threats
- Intense competition
- Regulatory changes
- Data security breaches
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- GOOG
- AAPL
- GRMN
Competitive Landscape
Aimei Health Technology Co., Ltd Right's advantages include innovative products and a strong brand reputation. Disadvantages include limited market reach and high research and development costs.
Major Acquisitions
Remote Monitoring Solutions Inc.
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded Aimei's remote patient monitoring capabilities.
Growth Trajectory and Initiatives
Historical Growth: Aimei Health Technology Co., Ltd Right has experienced strong growth in recent years, driven by its innovative products and expanding market reach.
Future Projections: Analysts project continued growth for Aimei Health Technology Co., Ltd Right, with revenue expected to reach $100 million in the next year.
Recent Initiatives: Aimei Health Technology Co., Ltd Right recently launched a new telehealth platform and expanded its sales team.
Summary
Aimei Health is experiencing good revenue growth and has a strong brand. Innovation and new products are helping to capture more market share, but competition is high. Maintaining its growth trajectory depends on effective management of R&D costs and aggressive expansion. Aimei needs to monitor for data security breaches.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical Data
- Analyst Estimates (Fictional)
Disclaimers:
The information provided is for illustrative purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.